USPTO serial 87284557
Serial No. 87284557
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 16, 2018
- Examiner
- REEVES, APRIL ELIZABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with Serial No. 87284557?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin D. McCarthy
Kevin D. McCarthy Roach Brown McCarthy & Gruber, P.C.424 Main Street1920 Liberty BuildingBUFFALO, NY 14202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ (Based on 44(e)) biological preparations featuring antibodies for the treatment of cancer, inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; anti-cancer preparations; biological preparations for the treatment of cancer inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; biopharmaceuticals for the treatment of cancer; diagnostic reagents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases ] | SECTION 8 - CANCELLED | — |
| 042 | (Based on 44(e)) (Based on Use in Commerce) Drug discovery services; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics; research and development in the field of diagnostic preparations; research in the field of pharmacogenetics; conducting clinical trials for pharmaceuticals; pharmaceutical research and development; research and development in the field of pharmaceuticals for the pharmaceutical industry; conducting early evaluations in the field of new pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; structural and functional analysis of genomes; DNA screening for scientific research purposes; biochemical research and analysis; laboratory research in the field of pharmaceuticals; research and development services in the field of immunology; medical research in the nature of computerized genetic analysis of DNA | ACTIVE | Sep 8, 2004 |
| 045 | [ (Based on 44(e)) Licensing of intellectual property rights ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 10, 2024 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 10, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 27, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 16, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 16, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 31, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 31, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 11, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 24, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 20, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 6, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 6, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 6, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 26, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 14, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 14, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 14, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 20, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 10, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2017 | NWAP | NEW APPLICATION ENTERED | — |